SE7706692L - Forfarande for framstellning av 3-(oxiderad alkyl)-1,9-dihydroxi-resp -1-hydroxi-9-keto-dibenso (b,d,) pyraner - Google Patents

Forfarande for framstellning av 3-(oxiderad alkyl)-1,9-dihydroxi-resp -1-hydroxi-9-keto-dibenso (b,d,) pyraner

Info

Publication number
SE7706692L
SE7706692L SE7706692A SE7706692A SE7706692L SE 7706692 L SE7706692 L SE 7706692L SE 7706692 A SE7706692 A SE 7706692A SE 7706692 A SE7706692 A SE 7706692A SE 7706692 L SE7706692 L SE 7706692L
Authority
SE
Sweden
Prior art keywords
dibenso
pyranes
resp
keto
dihydroxy
Prior art date
Application number
SE7706692A
Other languages
English (en)
Other versions
SE413779B (sv
Inventor
D S Fukuda
B J Abbott
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7706692L publication Critical patent/SE7706692L/sv
Publication of SE413779B publication Critical patent/SE413779B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • Y10S435/834Bacillus cereus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/931Mucor

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7706692A 1976-06-09 1977-06-08 Mikrobiologiskt forfarande for framstellning av 3-(ocidrad alkyl)-1,9-dihydroxi-respektive-1-hydroxi-9-keto-dibenso(b,d)pyraner genom anvendning av en stam av mikroorganismen bacillus cereus SE413779B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/694,512 US4064009A (en) 1976-06-09 1976-06-09 Novel 3-(oxygenated alkyl)-1,9-dihydroxy and 1-hydroxy-9-keto dibenzo[b,d]py

Publications (2)

Publication Number Publication Date
SE7706692L true SE7706692L (sv) 1977-12-10
SE413779B SE413779B (sv) 1980-06-23

Family

ID=24789127

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706692A SE413779B (sv) 1976-06-09 1977-06-08 Mikrobiologiskt forfarande for framstellning av 3-(ocidrad alkyl)-1,9-dihydroxi-respektive-1-hydroxi-9-keto-dibenso(b,d)pyraner genom anvendning av en stam av mikroorganismen bacillus cereus

Country Status (28)

Country Link
US (2) US4064009A (sv)
JP (1) JPS52151173A (sv)
AR (1) AR214636A1 (sv)
AT (1) AT356049B (sv)
AU (1) AU508677B2 (sv)
BE (1) BE855347A (sv)
BG (1) BG30773A3 (sv)
CA (1) CA1097237A (sv)
CH (1) CH640000A5 (sv)
CS (1) CS189599B2 (sv)
DD (1) DD131020A5 (sv)
DE (1) DE2725713A1 (sv)
DK (1) DK144971C (sv)
ES (1) ES459644A1 (sv)
FR (1) FR2354326A1 (sv)
GB (1) GB1583062A (sv)
GR (1) GR66428B (sv)
HU (1) HU174139B (sv)
IE (1) IE44992B1 (sv)
IL (1) IL52248A (sv)
NL (1) NL7706276A (sv)
NZ (1) NZ184332A (sv)
PH (1) PH12513A (sv)
PL (1) PL106942B1 (sv)
PT (1) PT66627B (sv)
RO (1) RO73175A (sv)
SE (1) SE413779B (sv)
ZA (1) ZA773467B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948732A (en) * 1989-02-10 1990-08-14 Schering Corporation Microbiological chiral reduction of carbonyl groups
DE4034218A1 (de) * 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
IL145470A0 (en) 1999-03-22 2002-06-30 Immugen Pharmaceuticals Inc Compositions for the treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20020137802A1 (en) * 2000-09-28 2002-09-26 Travis Craig R. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822188A (en) * 1972-10-19 1974-07-02 Abbott Lab Method of producing 1,4'-dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo(b,d)pyran
DE2335136A1 (de) * 1973-07-06 1975-01-16 Schering Ag 7-hydroxy-delta hoch 8-tetrahydrocannabinole

Also Published As

Publication number Publication date
IE44992B1 (en) 1982-06-02
GB1583062A (en) 1981-01-21
NZ184332A (en) 1978-09-20
PL106942B1 (pl) 1980-01-31
RO73175A (ro) 1981-11-24
BE855347A (fr) 1977-12-05
DK144971B (da) 1982-07-19
NL7706276A (nl) 1977-12-13
US4064009A (en) 1977-12-20
FR2354326A1 (fr) 1978-01-06
AT356049B (de) 1980-04-10
PL198731A1 (pl) 1978-04-10
PT66627A (en) 1977-07-01
IL52248A (en) 1980-09-16
CH640000A5 (de) 1983-12-15
ATA402377A (de) 1979-09-15
ES459644A1 (es) 1978-04-01
FR2354326B1 (sv) 1980-02-08
PH12513A (en) 1979-04-20
HU174139B (hu) 1979-11-28
SE413779B (sv) 1980-06-23
CA1097237A (en) 1981-03-10
AR214636A1 (es) 1979-07-13
DK247077A (da) 1977-12-10
BG30773A3 (en) 1981-08-14
PT66627B (en) 1978-11-09
DD131020A5 (de) 1978-05-24
AU508677B2 (en) 1980-03-27
JPS52151173A (en) 1977-12-15
AU2593577A (en) 1978-12-14
IE44992L (en) 1977-12-09
IL52248A0 (en) 1977-08-31
DE2725713A1 (de) 1977-12-22
GR66428B (sv) 1981-03-23
ZA773467B (en) 1979-01-31
CS189599B2 (en) 1979-04-30
US4104282A (en) 1978-08-01
DK144971C (da) 1982-12-13

Similar Documents

Publication Publication Date Title
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
NO147386C (no) Fremgangsmaate for fremstilling av forbedrete bitumer/polymerblandinger.
DK55477A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
NO771277L (no) Fremgangsm}te for fremstilling av aromatiske uretaner
NO770183L (no) Fremgangsm}te for fremstilling av heksanitrostilben.
DK55677A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO771159L (no) Fremgangsm}te ved fremstilling av titantetraklorid.
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE7706692L (sv) Forfarande for framstellning av 3-(oxiderad alkyl)-1,9-dihydroxi-resp -1-hydroxi-9-keto-dibenso (b,d,) pyraner
NO152260C (no) Fremgangsmaate ved fremstilling av formasjoner, fortrinnsvis underlagsfilt for gulvbelegg
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
FI773051A (fi) Centrifug med vibrationsdaempning
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
NO150087C (no) Fremgangsmaate for fremstilling av cellulosemasse
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
FI773050A (fi) Med vibrationsdaempning foersedd centrifug
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen